Meta Pixel

News and Announcements

Solar Analytics Granted Funding of $2.1 million from Federal Government Agency

  • Published April 13, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Sydney: Australian solar energy software provider Solar Analytics has raised $2.1 million in grant funding from Federal Government agency ARENA to support the accelerated deployment of smart monitoring for residential solar. The four year project with ARENA will result in 25,000 homes benefiting from the smart solar monitoring technology by 2020.

KEY TAKEAWAYS:

  • The Solar Analytics funding forms part of ARENA’s Advancing Renewables Programme – a $50m fund which aims to support projects that will reduce cost and increase use of renewable energy technologies.
  • Increase the energy yield of a rooftop solar system by over 15%, increase the financial return of residential solar power systems, and drive increased solar uptake through better financial returns and customer engagement.

“We expect the increased energy yield resulting from Solar Analytics monitoring will translate to more than 300MW of additional solar generation across Australia, simply by optimising currently installed systems,” said Solar Analytics co-founder and Director, Dr Renate Egan.

“Our software monitors the performance of rooftop solar PV and provides solar owners with their energy generation and use data. With data, Solar Analytics empowers everyday Australians to navigate the changing energy landscape and take advantage of the enormous opportunities that come with new energy technologies including storage and energy trading.”

Solar Analytics’ monitoring service provides performance monitoring and fault diagnosis of residential solar PV systems. The business has sold more than 12,000 solar monitoring units to solar households across Australia, and has recently entered the New Zealand and US markets.

Full Article

To request offer on Solar Analytics, please click the button below.

Request Offer

Capital Insights
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be  Attracting Big Pharma’s Attention

Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Join over 45,000+ sophisticated investors

Join Now